NOVARTIS AG-SPONSORED ADR (NVS)
US66987V1098 - ADR
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 2.88B | 3.40B | 3.75B | 3.25B | |||
| Cash Equivalents | 10.88B | 4.64B | 9.01B | 5.91B | 7.87B | |||
| Marketable Securities | 289.00M | 11.21B | 15.71B | 1.64B | 122.00M | |||
| Receivables | 9.54B | 9.89B | 9.62B | 10.04B | 10.34B | |||
| Inventories | 8.23B | 7.17B | 6.67B | 7.13B | 5.98B | |||
| Other Current Assets | 4.55B | 1.11B | 1.32B | 1.21B | 1.95B | |||
| Total Current Assets | 33.49B | 36.91B | 45.72B | 29.67B | 29.50B | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.28B | 12.20B | 13.11B | 13.94B | 13.75B | |||
| Investments And Advances | 2.43B | 1.61B | 2.27B | 11.61B | 10.54B | |||
| Goodwill | 29.52B | 29.30B | 29.59B | 30.00B | 26.52B | |||
| Intangibles | 28.00B | 31.64B | 34.18B | 36.81B | 28.79B | |||
| Other Non-Current Assets | 5.25B | 4.85B | 5.95B | 4.83B | 8.65B | |||
| Total Non-Current Assets | 77.49B | 80.54B | 86.08B | 98.11B | 88.87B | |||
| TOTAL ASSETS | 110.98B | 117.45B | 131.79B | 127.78B | 118.37B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 3.63B | 3.61B | 7.32B | 4.84B | |||
| Current Portion Of LT Debt. | 8.50B | 2.49B | 2.90B | 2.56B | 2.25B | |||
| Accrued Expenses | N/A | 5.33B | 5.10B | 5.34B | 5.06B | |||
| Accounts Payable | 5.35B | 5.15B | 5.55B | 5.40B | 5.42B | |||
| Other Current Liabilities | 18.06B | 12.05B | 13.05B | 12.44B | 10.69B | |||
| Total Current Liabilities | 31.91B | 28.66B | 30.21B | 33.06B | 28.26B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 19.80B | 21.78B | 24.52B | 27.98B | 22.06B | |||
| Deferred Taxes/Income | 2.53B | 2.69B | 3.07B | 3.14B | 5.87B | |||
| Other Non-Current Liabilities | 4.81B | 4.91B | 6.17B | 6.93B | 6.63B | |||
| Total Non-Current Liabilities | 27.22B | 29.45B | 33.93B | 38.12B | 34.63B | |||
| TOTAL LIABILITIES | 59.13B | 58.11B | 64.14B | 71.18B | 62.90B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 51.06B | 63.54B | 70.99B | 57.16B | 59.27B | |||
| Minority Interest | 83.00M | 81.00M | 170.00M | 69.00M | 72.00M | |||
| Common Shares | 842.00M | 890.00M | 901.00M | 913.00M | 936.00M | |||
| Treasury Stock | -52.00M | -92.00M | -48.00M | -53.00M | -80.00M | |||
| Other Shareholders' Equity | N/A | -4.80B | -4.19B | -1.42B | -4.66B | |||
| Shares Outstanding | 2.04B | 2.09B | 2.21B | 2.23B | 2.24B | |||
| Tangible Book Value per Share | -2.75 | -0.76 | 1.74 | -4.52 | 0.07 | |||
| Total Shareholders' Equity | 51.85B | 59.34B | 67.66B | 56.60B | 55.47B | |||
| TOTAL LIABILITIES AND EQUITY | 110.98B | 117.45B | 131.79B | 127.78B | 118.37B | |||
| Statistics | ||||||||
| Debt/Equity | 0.38 | 0.43 | 0.42 | 0.62 | 0.48 | |||
| Current Ratio | 1.05 | 1.29 | 1.51 | 0.90 | 1.04 | |||
| Return On Assets (ROA) | 6.89% | 5.92% | 18.23% | 6.32% | 9.91% | |||
| Return On Equity (ROE) | 14.75% | 11.72% | 35.51% | 14.26% | 21.15% | |||
| Return On Invested Capital (ROIC) | 14.83% | 12.17% | 10.67% | 10.56% | 10.44% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 17.27% | 14.69% | 13.94% | 11.41% | 11.40% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 113.03% | 71.94% | 67.19% | 38.93% | 31.32% | |||
All data in USD